These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4756344)

  • 1. [Critical review of clinical experimentation with clofibrate in coronary disease].
    Azzena D; Astengo F
    Minerva Cardioangiol; 1973; 21(7):497-502. PubMed ID: 4756344
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnosis and treatment of risk factors in chronic ischemic heart disease].
    Neugebauer A; Trenckmann H; Duck HJ; Fleischmann HJ; Schauer J
    Z Gesamte Inn Med; 1974 Oct; 29(19):809-14. PubMed ID: 4460433
    [No Abstract]   [Full Text] [Related]  

  • 3. [The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications].
    Cucinotta D; Ferretti PG; Daccò L; Mazzera F
    G Clin Med; 1977; 58(11-12):475-86. PubMed ID: 608558
    [No Abstract]   [Full Text] [Related]  

  • 4. [Classification of hyperlipoproteinemias in hospitalized patients].
    Mombelloni P; Radaeli E; Albertini A; Prandini BD; Spandrio L
    G Clin Med; 1972 Mar; 53(3):121-31. PubMed ID: 4649402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Classification of hyperlipoproteinaemia in primary gout].
    Mertz DP; Schwoerer P; Babucke G
    Dtsch Med Wochenschr; 1972 Apr; 97(15):600-4. PubMed ID: 5026795
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperlipiemia and its therapy by clofibrate].
    Nakano M; Nakamura Y
    Iryo; 1969 Dec; 23(12):1473-8. PubMed ID: 5381198
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of long-term administration of clofibrate on the composition of blood lipids in patients with atherosclerosis.
    Poleszak J; Korolko A
    Pol Med J; 1972; 11(2):250-6. PubMed ID: 5071512
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of drugs affecting lipids on atherosclerosis.
    Ditschuneit H
    Horm Metab Res; 1974; Suppl 4():191-4. PubMed ID: 4421312
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy and prevention of arteriosclerosis].
    Gerö S
    Z Alternsforsch; 1971; 24(4):301-20. PubMed ID: 4110936
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical picture of the type-3-hyperlipoproteinemia].
    Reimers HJ; Huth K; Schoenborn W; Fuhrmann W
    Verh Dtsch Ges Inn Med; 1971; 77():596-9. PubMed ID: 5155905
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of chronic ischemic cardiopathy with a combination of pyridinolcarbamate and clofibrate].
    Guerrera G; Melina D
    Clin Ter; 1980 Mar; 92(5):533-47. PubMed ID: 7449327
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epidemiological studies of some electrocardiographic changes and their correlation with lipemic balance in evaluation of atherogenetic risks].
    Mincu I; Câmpeanu S; Dumitrescu C; Mihalache N; Mironescu V; Aron L; Georgescu S; Stănescu J; Baboia D; Bruckner I
    Med Interna (Bucur); 1972 Dec; 24(12):1463-78. PubMed ID: 4655568
    [No Abstract]   [Full Text] [Related]  

  • 14. Trial of clofibrate.
    Br Med J; 1972 Jan; 1(5795):311. PubMed ID: 5008491
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in free fatty acid concentration under glucose loading in patients with alimentary obesity].
    Mokina MN
    Vopr Pitan; 1972; 31(4):59-63. PubMed ID: 4644439
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the initial paths of exogenous lipid tranformation in patients with different diseases].
    Shaternikov VA; Loranskaia TI; Beiul EA; Paramonova EG; Oleneva VA; Tuzhilin SA; Savchuk LA
    Vestn Akad Med Nauk SSSR; 1968; 23(3):69-72. PubMed ID: 5746877
    [No Abstract]   [Full Text] [Related]  

  • 17. The identification of risk factors in normal children in the development of arteriosclerosis.
    Drash A; Hengstenberg F
    Ann Clin Lab Sci (1971); 1972; 2(5):348-59. PubMed ID: 5082977
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
    Valiensi M; Riboli E; Lombardi M
    Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood serum lipids in ischemic disease of the heart].
    Balgma K; Kont M; Fel'dman S
    Sov Med; 1970 Mar; 33(3):134-5. PubMed ID: 5419164
    [No Abstract]   [Full Text] [Related]  

  • 20. [The fatty acid composition of serum lipids in atherosclerosis].
    Alimova EK; Endakova EA
    Vopr Med Khim; 1970; 16(3):310-6. PubMed ID: 5455888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.